Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia.

By H. Zeisler, E. Llurba, F. Chantraine, M. Vatish, A. Staff, M. Sennström, M. Olovsson, S. Brennecke, H. Stepan, Deirdre Allegranza and 4 more. New England Journal of Medicine, 2016

1,300 citations recorded by the source corpus.

Subfields: Immunology, Obstetrics and Gynecology, Pediatrics, Perinatology and Child Health

View Paper: https://www.semanticscholar.org/paper/aef23a8a467e1c42537a6956f0a3b454577f52ea

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. L. Magee
2. M. Brown
3. D. Hall
4. S. Gupte
5. S. Karumanchi
6. A. Hennessy
7. A. Staff
8. F. McCarthy

Citations in the corpus

• The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice. (2018, background): “The PROGNOSIS study (54) found that a sFlt1/PlGF ratio <38 could reliably rule out development of pre-eclampsia for the next 7 days in women with a wide range of inclusion criteria; this finding may not be of any clinical advantage in centres already established for regular antenatal follow up but m”
• The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice. (2021, background): “• Second, women with ‘suspected pre-eclampsia ’ have often been studied where pre-eclampsia was defined only by gestational hypertension and proteinuria [37,47,57], or women with new dipstick proteinuria did not necessarily undergo confirmatory testing for proteinuria prior to enrolment [36,38].”